technology transfer the secret engine behind israeli success
DESCRIPTION
TRANSCRIPT
Technology Transfer: The Secret Engine Behind Israel’s Success Yaacov Michlin, CEO
2
Technology Transfer: The Secret Engine Behind Israel’s Success
Academic innovation is at the forefront of the Israeli economy.
Israeli technology transfer companies promote the transfer of
academic-based technologies for the benefit of society and
have a direct contribution to the country’s industrial and
scientific success.
Without Technology Transfer We Would Not Have:
Without Technology Transfer We Would Not Have:
Mobileye Pepper Hybrids Polymerico Fiber Optics
Cherry Tomato Hybrids
Sandisk Chip Motorola Barcode Reader
NDS Smart Card
5
Israeli Tech Transfer Companies
Yissum -a leading
member of the ITTN *
Commercializing Academic Intellectual Property Into Marketable Products
* By number of available technologies
6
Remarkable Numbers:
Each year Israeli technology transfer companies generate a total of over NIS 1 Billion in royalties.
Over NIS 100 Million are invested by industrial companies in scientific research collaborations at universities
About 150 new technologies are licensed from Israeli universities and research institutes each year
An average of 15 new companies that are based on academic inventions are started every year
Yissum (Hebrew University) and Yeda (Weizman Institute) are rated among the top 10 tech transfer companies worldwide in terms of revenues*
* AUTM survey 2010
7
Dozens of Successful Israeli Start Ups Are Based On Academic Technologies
15 Public Spin-Off Companies
Investment In Academic Research: Tomorrow’s New Technologies
Investment In Early Stage Research
High Risk = High Yield
Early Stage Project Funding
Long-Term Royalty-Based Funding Model
Investment in Spin Off
Companies
9
10
Yissum: 47 Years of Transferring Technologies
Products based on Hebrew University technologies & commercialized by Yissum generate over $2 Billion in annual sales
7,077 patents
2,023 inventions
530 licenses
72 spin-offs
11
Yissum In Numbers:
Yissum generates approx. $11M yearly from direct research collaborations with industrial partners.
These generate about 300 new laboratory positions every year at the Hebrew University.
60 new license agreements are signed each year with commercial partners
5 new start up companies are created each year
Yissum’s Biotech Product Pipeline:
Vekacia ® (Novagali)
Cyclokat ® (Novagali)
Ladostigil (Avraham)
BC819 (Biocancell)
Anti Angiogenic (Tiltan)
MRX4 (Morria)
Acc. Levodopa (Intech)
LABR-312 ( Biorest)
CatioProst ® (Novagali)
Protexia (Pharmathene)
Apocell (Enlivex)
VaxiSome® (Nasvax)
EPOdure (Medgenics)
AB103 (Atox Bio)
Cortiject ® (Novagali)
Phase I Phase II Phase III
MRX6 (Morria)
Acc. Zalepon (Intech)
Acc. Baclofen (Intech)
PRX105 (Protalix)
Bridging the Valley of Death
Academic Grants
Baby Seed Kamin/Nofar
Magneton, Incubators
Independent Companies
Extensive Long Term
Collaboration
An internal Yissum Program
Such as Roche
Funding through the OCS
The Valley of Death
Yissum’s services for the researchers – aimed at bridging the gap between
academic financing and commercialization stage
Direct investment in one of Yissum’s 45 spin off companies
13
Yissumiot
14
Among the world’s top 10 techtransfer companies
Over 50 years of best practices intechnology transfer
Immediate and long-term benefit for the Israeli economy
Bridging the gap between academia and industry is our challenge and virtue
Invest In Academic Research- Invest in Israel’s Future
